Trials / Terminated
TerminatedNCT05034978
Novel SARS-CoV-2 Point-of-care Testing
Point-of-care Testing for Improving the Detection of SARS-CoV-2 Infection in Healthcare Setting
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The aim of the project is to study the feasibility of implementing a novel point-of-care test (POCT) for rapid detection of SARS-CoV-2 infection. A CRISPR-based detection kit would be piloted for testing of suspected SARS-CoV-2 infection in healthcare setting, with the objectives of evaluating the performance of the new test in the detection of SARS-CoV-2, and assessing the practicability of the new test for diagnosing SARS-CoV-2 infection in healthcare settings.
Detailed description
A CRISPR-based lateral flow assay (LFA) detection kit would be designed and developed for testing for the presence of SARS-CoV-2. The aim of the project is to study the feasibility of implementing the novel point-of-care test (POCT) for rapid detection of SARS-CoV-2 infection in health service setting, with the following objectives: (b) Evaluation of the performance of novel POCT in comparison with conventional quantitative PCR in diagnosis SARS-CoV-2 infection and (c) Assessment of the practicability of LFA-CRISPR-based tests in the operating environments in healthcare settings. Patients who are admitted to the isolation wards of Prince of Wales Hospital, Hong Kong would be invited to join the study. A total of 600 persons with suspected SARS-CoV-2 infection presenting with different symptomatology and epidemiological history will be recruited. Nasal, deep saliva and/or mouth gargle samples will be collected from all recruited subjects in accordance with standard clinical protocol. The samples would be tested for SARS-CoV-2 by the new Point-of-care test, in parallel with standard diagnostic testing of the hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | evaluating the performance of a novel point-of-care test |
Timeline
- Start date
- 2021-03-16
- Primary completion
- 2022-07-31
- Completion
- 2022-07-31
- First posted
- 2021-09-05
- Last updated
- 2023-02-09
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05034978. Inclusion in this directory is not an endorsement.